139 related articles for article (PubMed ID: 10963287)
1. Effectiveness of specific immunotherapy in the treatment of asthma: a meta-analysis of prospective, randomized, double-blind, placebo-controlled studies.
Ross RN; Nelson HS; Finegold I
Clin Ther; 2000 Mar; 22(3):329-41. PubMed ID: 10963287
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: an analysis of randomized, prospective, single- or double-blind, placebo-controlled studies.
Ross RN; Nelson HS; Finegold I
Clin Ther; 2000 Mar; 22(3):342-50. PubMed ID: 10963288
[TBL] [Abstract][Full Text] [Related]
3. [Allergen-specific immune therapy in the treatment of asthma].
Malling HJ
Ugeskr Laeger; 2000 Jan; 162(4):477-9. PubMed ID: 10697443
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of specific immunotherapy in the treatment of hymenoptera venom hypersensitivity: a meta-analysis.
Ross RN; Nelson HS; Finegold I
Clin Ther; 2000 Mar; 22(3):351-8. PubMed ID: 10963289
[TBL] [Abstract][Full Text] [Related]
5. Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy.
Kopp MV; Hamelmann E; Bendiks M; Zielen S; Kamin W; Bergmann KC; Klein C; Wahn U;
Pediatr Allergy Immunol; 2013 Aug; 24(5):427-33. PubMed ID: 23799935
[TBL] [Abstract][Full Text] [Related]
6. Role of immunmodulators in allergen-specific immunotherapy.
Kopp MV
Allergy; 2011 Jun; 66(6):792-7. PubMed ID: 21332502
[TBL] [Abstract][Full Text] [Related]
7. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
Ibáñez Sendín MD
Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
[TBL] [Abstract][Full Text] [Related]
9. A three-year prospective study of specific immunotherapy to inhalant allergens: evidence of safety and efficacy in 300 children with allergic asthma.
Cantani A; Arcese G; Lucenti P; Gagliesi D; Bartolucci M
J Investig Allergol Clin Immunol; 1997; 7(2):90-7. PubMed ID: 9161933
[TBL] [Abstract][Full Text] [Related]
10. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
[TBL] [Abstract][Full Text] [Related]
11. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
Roberts G; Hurley C; Turcanu V; Lack G
J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
[TBL] [Abstract][Full Text] [Related]
12. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
Silny W; Czarnecka-Operacz M
Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
[TBL] [Abstract][Full Text] [Related]
13. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
[TBL] [Abstract][Full Text] [Related]
14. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
Halken S
Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
[TBL] [Abstract][Full Text] [Related]
15. Oral allergy syndrome in patients with airborne pollen allergy treated with specific immunotherapy.
Czarnecka-Operacz M; Jenerowicz D; Silny W
Acta Dermatovenerol Croat; 2008; 16(1):19-24. PubMed ID: 18358104
[TBL] [Abstract][Full Text] [Related]
16. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms.
Crimi N; Li Gotti F; Mangano G; Paolino G; Mastruzzo C; Vancheri C; Lisitano N; Polosa R
Ann Ital Med Int; 2004; 19(2):98-108. PubMed ID: 15317270
[TBL] [Abstract][Full Text] [Related]
17. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials.
Penagos M; Compalati E; Tarantini F; Baena-Cagnani R; Huerta J; Passalacqua G; Canonica GW
Ann Allergy Asthma Immunol; 2006 Aug; 97(2):141-8. PubMed ID: 16937742
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
Polzehl D; Keck T; Riechelmann H
Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
[TBL] [Abstract][Full Text] [Related]
20. A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma.
Rak S; Heinrich C; Jacobsen L; Scheynius A; Venge P
J Allergy Clin Immunol; 2001 Dec; 108(6):921-8. PubMed ID: 11742269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
